Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 13;9:717462. doi: 10.3389/fcell.2021.717462

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Tian, Hou, Zhou, Qiu, Du, Gu, Yin and Wang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

KM and ROC curves for patients stratified by molecular subtype and metastasis status. KM analysis showed that patients in the low-risk group had significantly better DSS in the LumA-like (A), basal-like (G), normal-like (I), and M0 (K) subgroups, but not in the LumB-like (C) or HER2 (E) subgroups. ROC analysis showed that the five-miRNA signature exhibited high sensitivity and specificity in predicting the prognosis of patients with BC in the LumA-like (B), basal-like (H), normal-like (J), and M0 (L) subgroups, but not the LumB-like (D) or HER2 (F) subgroups.